According to CECC, Disease Control Butler's Taiwan V-Watch System is officially available for the public to report health status after COVID-19 vaccination.
On March 22, the Central Epidemic Command Center announced that Taiwan's COVID-19 vaccination would start today. In order to efficiently monitor the health of immunized individuals, the Taiwan Centers for Disease Control (Taiwan CDC) worked with HTC Corporation’s healthcare unit DeepQ to establish the Taiwan V-Watch System (hereinafter "V-Watch System") for health reporting after COVID-19 vaccination on Taiwan CDC’s official LINE chatbot Disease Control Butler. The V-Watch System allows members of the public to regularly report their health status after they receive vaccination.
On March 19, the Central Epidemic Command Center (CECC) announced that according to the recommendations made in the expert meeting of the Advisory Committee on Immunization Practices (ACIP), the clinical benefits of the AstraZeneca vaccine in preventing COVID-19 infection and severe symptoms after infection outweigh the risk of adverse reactions after vaccination, and it is recommended that the AstraZeneca vaccine be offered to the priority groups as planned.
The CECC pointed out that some of the 116,500 doses of the AstraZeneca vaccine were transported to 57 injection sites today. These vaccine doses are scheduled to be offered to medical personnel who work at COVID-19 wards or negative pressure isolation wards, or who are responsible for specimen collection starting March 22.
As taking contraceptive pills and undergoing hormone therapy are risk factors for blood clotting, people receiving these two treatments are advised not to receive COVID-19 vaccination at this stage. Furthermore, members of the public who wish to get vaccinated are advised to consult their doctor and assess related risks before immunization.
More articles:
President Tsai praises Taiwan’s contributions toward development of TCM
Taiwan ranks third in the world of global pandemic prevention performance
